Home / Investors

PE/VC investors

Private Equity (PE) and Venture Capital (VC) investors are the catalysts of innovation and growth in the business world. PE firms primarily target established companies, seeking to optimize operations and unlock value through strategic investments and management expertise. They focus on long-term growth and profitability, often preparing businesses for a future sale or IPO. VC investors, by contrast, are the adventurers of finance, injecting capital into high-potential startups and early-stage companies. They embrace risk for the possibility of outsized returns, often becoming invaluable advisors. Both investor types not only bring capital but also strategic guidance, industry connections, and market insights, propelling their portfolio companies towards success.

Investors (8,142)
Investor
Description
More information
BioRock Ventures BioRock Ventures
BioRock Ventures is a seed venture capital fund based in the Bay Area, California. The firm is led by Mary Wheeler, a Kauffman Fellow and founding managing partner with extensive experience in therapeutics startups and major pharmaceuticals roles, including strategic positions at Johnson & Johnson and Allergan. BioRock Ventures is distinguished by its deep expertise in the life sciences sector, particularly in therapeutics, and its emphasis on seed to pre-IPO investments across various therapeutic modalities. The firm focuses on seed-sized investments into life science companies developing novel FDA-regulated therapeutic drugs. BioRock Ventures invests in all disease areas and stages, from angel and seed to Series A through pre-IPO/M&A. The geographic focus encompasses primarily North America, with a specialized focus on therapeutics innovation. The firm currently manages two funds: Fund I and Fund II, concentrating on seeding next-generation therapeutics. Notable investments from BioRock Ventures include Immusoft - a company focused on engineered B cell therapies, AN2 Therapeutics - known for its novel small molecule therapeutics, Primmune Therapeutics - specializing in immune system therapies, PTM Therapeutics, and Vaxcyte. These investments underscore the firm’s strategic focus on therapeutics with significant potential for clinical advancement and regulatory approval.
View
Bios Partners Bios Partners
Bios Partners is a venture capital firm based in Fort Worth, Texas, founded in 2014 by Aaron Fletcher and Leslie W. Kreis, Jr. The firm focuses on identifying advanced biotech opportunities in overlooked and under-invested markets across the United States. With a team of 10 professionals, Bios Partners leverages its combined 80 years of experience in hedge funds, private equity, clinical drug development, and public pharma/biotech analysis to cultivate and bring innovative companies to market. The firm invests in the healthcare and life sciences sectors, targeting seed-stage to later-stage companies. Bios Partners is particularly interested in disrupting geographic favoritism by investing in compelling science across the Central US. The firm manages several funds, including Bios Fund II NT, LP, with an AUM of $5 million. Their investment strategy includes a focus on the New England, Southeast, South, and West Coast regions of the United States. Notable investments by Bios Partners include Actuate Therapeutics - drug discovery, Cognition Therapeutics - neurodegenerative disease treatment, Encore Vision - ophthalmic pharmaceuticals, I-Lumen Scientific - medical devices, and Immusoft - cell therapy. These investments highlight the firm's commitment to advancing healthcare innovations.
View
BioStar Ventures BioStar Ventures
BioStar Capital is a venture capital firm based in Charlevoix, Michigan, founded in 2005. The firm is led by a team of healthcare clinicians, medical thought leaders, and financial professionals, focusing on transformative medical technologies. BioStar Capital is known for its unique collaboration between clinical expertise and business acumen, which has consistently produced life-changing outcomes for patients and rewarding returns for investors. The firm invests primarily in the medical technology sector, including surgical and therapeutic devices. BioStar Capital typically participates in early to late-stage investments, with a focus on North America. The firm manages several funds, including BioStar Ventures V, which closed in 2021. BioStar Capital's strategic partners and limited partners include leading healthcare institutions and industry experts. Notable investments by BioStar Capital include Amplitude Vascular Systems - developer of the Pulse IVL platform, Field Medical - surgical devices, Nectero Therapeutics - therapeutic devices, REVA Medical - therapeutic devices, Versa Vascular - therapeutic devices, and Medical Microinstruments - surgical devices.
View
Biotechnology Fund Biotechnology Fund
The Biotechnology Fund is a venture capital firm based in Iran, specializing in biotechnology investments. This organization focuses on fostering innovative biotech developments and supporting the bio-innovation ecosystem in the region. Their team consists of experts across various biotech sub-fields with a robust background in venture capital investments. The firm makes extensive efforts to support new biotechnology ventures that have the potential to revolutionize the industry locally and internationally. Biotechnology Fund primarily invests in early-stage biotechnology companies, providing venture capital support and financial advisory to innovative projects. Their investment strategy encompasses seed to late-stage investments, targeting companies within Iran. They provide resources for financial consulting, project evaluation, and fundraising, essential for emerging biotech firms. The firm collaborates with various strategic partners in science and technology sectors to ensure effective growth and support for their portfolio companies. The firm has supported multiple biotech projects and has actively participated in numerous technology exhibitions and conventions. While specific notable investments are not listed, the firm is broadly engaged in collaborations that advance the biotechnology sector in Iran, particularly focusing on innovative and scalable technologies. They aspire to create a vibrant biotech ecosystem through their strategic investments and partnerships.
View
Biovance Capital Partners Biovance Capital Partners
Biovance Capital Partners is a biotech investor based in Portugal, focusing on early-stage biopharma companies across Europe. Founded with a commitment to enhancing transformative medical treatments, the team comprises experienced professionals with backgrounds in academia and industry, including PhDs and MDs from institutions such as Harvard and Imperial College. Biovance leverages its extensive network to support pioneering entrepreneurs in bringing novel therapies to market. The firm is distinguished by its bespoke investment approach, tailored to the unique needs of biopharmaceutical ventures. Biovance primarily invests in early-stage ventures, including seed and Series A rounds, with a strict focus on biotech companies involved in therapeutic development across all modalities. Typical investments range between $1-5 million, with support from the European Investment Fund and other public and private partners. Biovance Capital is committed to European coverage, with a special emphasis on Southern Europe. Its Fund I is €60 million, and the firm maintains a strategic partnership with international research institutes and accelerators. Notable investments include Vaxdyn - specializing in vaccines, where Biovance Capital co-led a Series A round. The firm's portfolio showcases a blend of innovative therapeutics companies, indicating a focus on building long-term value through strategic collaborations and leveraging a clear regulatory pathway to market.
View
BioVentures Investors BioVentures Investors
BioVentures Investors is a venture capital firm specializing in MedTech investments, headquartered in Westborough, Massachusetts. The firm was founded to focus solely on the MedTech sector, providing both financial and strategic support. The team comprises experienced professionals with expertise in regulatory affairs, clinical application, and financial management, dedicated to transforming healthcare through technology. Their collaborative approach with portfolio companies distinguishes them in the industry. The firm invests in emerging and growth-stage MedTech companies, with a preference for next-generation implantable and disposable devices, tools, diagnostics, imaging, and healthcare IT. They typically engage in late-stage growth capital deals or early-stage investments, adapting their strategy to meet company needs. BioVentures manages significant funds, including the BioVentures MedTech Growth Capital Fund and the BioVentures MedTech Innovation Fund, although the total assets under management are not disclosed. Notable investments by BioVentures include a range of companies focused on improving medical technology and healthcare solutions. Their portfolio includes leading firms in the MedTech sector that address high-quality and efficient healthcare delivery—though specific company names are not provided on their site.
View
BIP Capital LLC BIP Capital LLC
BIP Capital is a private market operating system based in Atlanta, Georgia, founded in 2018. The firm is designed to support independent advisory firms by integrating alpha-seeking investment strategies and proprietary market intelligence. BIP Capital differentiates itself by providing direct access to investment professionals and offering transparency at the portfolio level, unlike other platforms that focus on distribution volume. The firm invests in private credit, venture, and growth equity strategies, targeting high-growth private companies at early stages of value creation. BIP Capital focuses on sectors such as AI and service industries poised for productivity gains. The firm does not specify a typical check size but emphasizes disciplined manager selection and conviction-driven investments. BIP Capital's platform serves a wide range of advisory firms, from emerging to institutional-scale practices. Notable investments by BIP Capital are not explicitly listed in the available sources, indicating a focus on maintaining confidentiality and discretion in their portfolio management.
View
BIP Investment Partners S.A. BIP Investment Partners S.A.
BIP Investment Partners S.A. is a private equity investor based in Luxembourg, founded in 2000. The firm was established as BGL Investment Partners S.A. and later transformed into BIP Investment Partners S.A. after a series of ownership changes involving Banque Générale du Luxembourg and various Luxembourg families. The team, located in the international hub of Luxembourg, comprises a multi-national and multi-lingual group with over 110 years of combined investment experience, committed to executing investment strategies and maximizing growth for their investee companies. BIP seeks investments across various sectors including, but not limited to, industrials, consumer products, and healthcare services, with a particular focus on European markets. Their funding vehicle, BIP IV, caters to mid-market companies and aims to support long-term value creation. BIP adapts their investment approach to integrate Environmental, Social, and Governance (ESG) considerations as part of their commitment to sustainable investment practices. BIP's portfolio showcases various notable investments such as Enzymotec Ltd. in the biotechnological sector and collaborations with firms like Goldman Sachs Asset Management for strategic transactions. The firm aligns with long-term partners to extend their industry reach, though specific details on other investments are not extensively documented.
View
BIP Ventures BIP Ventures
BIP Ventures is a highly active venture capital firm based in Atlanta, with nearly two decades of experience in the industry. They focus on supporting high-growth companies in building market-leading businesses and creating long-term value for investors. They boast a team of experts who provide active partnership and drive competitive advantages, emphasizing strategic investment and scaling businesses. BIP Ventures is known for its hands-on approach, guiding their portfolio companies through growth challenges and operational rigor. BIP Ventures invests in high-growth, AI-enabled private companies primarily at the earliest stages of value creation. Their sector focus includes technology, AI, healthtech, and cybersecurity. The firm operates in North America with a particular emphasis on the Southeast region of the United States, reflecting its deep regional roots and expertise. While specific fund sizes and vintage years are not disclosed, the firm has made substantial investments throughout its portfolio and maintains a dynamic presence in the market. Some notable companies in BIP Ventures' portfolio include Pointivo - supply chain tracking, ObjectiveHealth - clinical trials, GloveBox - insurance management app, Proem Behavioral Health - health services, and Case Status - legal client communication. The firm has a reputation for being an impactful partner, providing strategic guidance and operational support to help its portfolio companies scale and succeed.
View
Birch Hill Equity Partners Birch Hill Equity Partners
Birch Hill Equity Partners is a Canadian mid-market private equity firm based in Toronto, founded in 1994. The firm is renowned for its extensive experience in driving growth across its portfolio, which comprises 74 companies to date. The Birch Hill team is characterized by its depth of experience, totaling over 200 years, drawn from diverse fields including operations, investment banking, consulting, engineering, accounting, and data analytics. A notable differentiator is their robust internal Data Science Team, which supports investment stages through data-driven decision making and analytics. Birch Hill focuses on partnering with growth-oriented companies in Canada and the United States, with company valuations ranging from $75 million to $3 billion. They primarily operate in the mid-market segment across various industries. Birch Hill manages over $6 billion in assets, deploying capital through multiple funds, including its latest fund, Birch Hill Equity Partners VII, with $2.6 billion. Their investment process is underscored by a sustainable, long-term growth strategy. Notable investments include a series of 74 portfolio companies, of which 60 have been fully realized. Details on specific investments are not publicly available from the current records. This emphasis on privacy underscores Birch Hill's commitment to sustained partnerships and strategic growth without extensive public disclosure.
View

Investor Database: Find Angel Investors, VCs & Private Equity Firms

Find angel investors, venture capital firms, and private equity investors worldwide.

Search thousands of active investors by stage, industry, and location. Built for founders, fundraising teams, and M&A advisors who need relevant investors fast.

Database at a Glance

  • 8,000+ investors
  • 119 countries covered
  • Angels, venture capital, and private equity in one platform
  • Filter by stage, industry, and location

A Searchable Directory of Active Investors

This is a global investor database built for fast, targeted discovery.

Instead of spreadsheets or generic lists, you can search verified angel investors, venture capital firms, and private equity funds actively investing across markets, industries, and stages.

Everything is structured to help you identify relevant investors quickly and move straight to outreach.

Private Equity List’s AI Search tool lets you describe your company or deal and returns investors with matching investment history, so you are not guessing who might be a fit.

Investor Database With Actionable Data

Every profile is designed to help you assess fit without unnecessary digging.

Each investor profile includes:

  • Investor or firm name
  • Investor type (Angel, Venture Capital, Private Equity)
  • Country and geographic focus
  • Investment stage preference
  • Industry and sector focus

This allows you to shortlist investors based on real criteria, not assumptions.

Global Coverage Across Angels, VC, and Private Equity

The directory supports fundraising and deal sourcing across regions and investor types.

  • Thousands of investors listed worldwide
  • Coverage across multiple countries
  • Angel investors, VC firms, and PE funds in one place
  • Continuously expanding investor coverage

Whether you’re raising early-stage capital or sourcing institutional investors, the database scales with your needs.

Filter Investors by Stage, Industry, and Location

Finding the right investors shouldn’t require manual sorting.

You can filter investors by:

  • Investor type (Angel, VC, Private Equity)
  • Industry and sector
  • Investment stage
  • Country and location

These filters help you focus only on investors aligned with your raise or transaction.

Built for Founders, Fundraising Teams, and Advisors

This investor database is designed for people actively sourcing capital or investors.

Startup Founders

Find investors aligned with your stage, sector, and geography. Build targeted investor lists and reduce time spent on cold outreach.

Fundraising and Growth Teams

Accelerate investor research, improve targeting, and support active fundraising with structured data.

M&A Advisors and Dealmakers

Identify investors and capital partners across regions and deal types. Source active capital faster with better precision.

Search, Shortlist, and Start Outreach

Using the database is straightforward and built for speed.

  1. Search investors using filters for stage, industry, and location
  2. Build a targeted investor shortlist
  3. Begin outreach or deal sourcing

Start Searching Investors Today

Access a global database of angel investors, venture capital firms, and private equity funds built for high-intent fundraising.

Our AI Search tool helps you quickly identify the most relevant investors based on stage, sector, geography, and real investment behaviour.

Search Investors

FAQs

An investor database typically includes structured investment data such as investor type, geographic focus, preferred investment stage, and industry or sector interests.
Yes, most comprehensive investor databases include angel investors alongside venture capital firms, private equity funds, and other early-stage investment sources.
The insight provided depends on how frequently the database is updated, but profiles generally reflect publicly available information on investment focus, stage, and location.
Yes, many investor databases include family office investors, allowing users to identify them by location, investment focus, and deal type.
Investor databases are commonly used by startup founders, fundraising teams, and advisors who need a structured way to research and identify relevant investors.